Executives at Emergent BioSolutions' Baltimore factory covered up quality control problems that led to more than 400 million doses of coronavirus vaccines needing to be trashed, congressional investigators said.
Tagged with: Congress Covid Emergent Biosolutions
Read More »
Emergent BioSolutions' Baltimore facility was found to be compliant after an inspection concerning its production of the Johnson & Johnson COVID-19 vaccine.
Tagged with: Covid Emergent Biosolutions vaccines
Read More »
The federal government has canceled a multimillion dollar deal with Maryland-based vaccine manufacturer Emergent BioSolutions.
Tagged with: Emergent Biosolutions vaccines
Read More »
Gaithersburg-based Emergent BioSolutions Inc. and Providence Therapeutics have entered into an agreement to support Providence's COVID-19 vaccine development.
Tagged with: Covid Emergent Biosolutions vaccines
Read More »
The FDA is allowing the problem-plagued Baltimore factory of Emergent BioSolutions to resume production of the Johnson & Johnson COVID-19 vaccine.
Tagged with: Emergent Biosolutions johnson & johnson vaccines
Read More »
Emergent BioSolutions Inc.’s ruination of 15 million doses of COVID-19 vaccine at its Baltimore plant was not as unexpected as the Gaithersburg-based company would have the public believe, an investor has alleged in a potential class-action lawsuit accusing the business ...
Tagged with: COVID-19 Emergent Biosolutions johnson & johnson Securities Exchange Act securities fraud vaccine
Read More »
A Gaithersburg life sciences firm that focuses on public health threats expects to receive $261 million after a federal agency exercised an option on its anthrax vaccine contract.
Tagged with: Emergent Biosolutions gaithersburg Montgomery County
Read More »
Maryland Daily Record Maryland's trusted source for business and legal news
